A multinational team analysing four TrialNet trials reports that children under eight years progressing rapidly to clinical type 1 diabetes

A novel [13C9,15N1]-glucagon tracer study in 12 healthy individuals undergoing multi-rate clamp visits demonstrates that glucose, not insulin, appears to

A post-hoc analysis of the SELECT trial examines obstructive sleep apnea (OSA) outcomes in adults with established cardiovascular disease and

A Diabetes Prevention Program Outcomes Study (DPPOS) analysis examines the association of randomization to metformin with prevalent cognitive impairment syndromes,

A pooled analysis of the SELECT, FLOW, and SOUL Phase 3 outcomes trials demonstrates that semaglutide reduces COVID-19-related complications and

A study reports that urinary post-translationally modified fetuin-A predicts renal outcomes independent of albuminuria and eGFR in type 2 diabetes,

An AdventHealth team reports that plasma-derived extracellular vesicle (EV) proteomics can distinguish partial clinical remission (PCR) in new-onset type 1

A study compares individualized care pathways against usual care for reducing prediabetes-to-diabetes conversion rates, addressing whether tailored, multi-dimensional intervention strategies

A dashboard-driven methodology for phenotyping high-utilization risk in pediatric type 1 diabetes provides a practical, deployable framework for identifying patients

A study reports that high-dose semaglutide is associated with preservation of kidney function in people living with obesity without diabetes,